Icosavax

AstraZeneca Buys into RSV Vaccine Market with Potential $1.1B Icosavax Purchase
BioSpace
Tue, 12/12/23 - 11:17 am
AstraZeneca
Icosavax
RSV
M&A
vaccines
Icosavax receives fast track designation for IVX-A12 vaccine candidate
Pharmaceutical Business Review
Wed, 02/22/23 - 09:54 am
Icosavax
IVX-A12
vaccines
RSV
hMPV
Icosavax's COVID-19 shot fails to deliver in early data, spurring debate about 'fatal flaw' in platform
Fierce Biotech
Mon, 03/28/22 - 10:28 am
Icosavax
vaccines
COVID-19
IVX-411
clinical trials
A biotech developing a synthetic biology Covid-19 vaccine comes up short in first data readout — and investors are fleeing
Endpoints
Fri, 03/25/22 - 10:44 am
Icosavax
vaccines
COVID-19
clinical trials
Biotech listings show signs of a slowdown
EP Vantage
Wed, 10/6/21 - 10:38 am
IPOs
Adagio Therapeutics
Caribou Biosciences
Erasca
DiCE Therapeutics
Icosavax
Icosavax’s $182M IPO haul is key for RSV, but eyes are on its Covid vaccine too
MedCity News
Sun, 08/1/21 - 11:53 pm
IPOs
Icosavax
RSV
vaccines
Three Biopharma Companies Made Public Debut on Nasdaq Exchange
BioSpace
Thu, 07/29/21 - 10:59 pm
IPOs
Nuvalent
Rallybio
Icosavax
NASDAQ
Nuvalent joins the IPO party less than 6 months after launch, while Icosavax kicks its 'soccer ball' VLPs to Nasdaq
Endpoints
Wed, 07/7/21 - 11:07 am
Nuvalent
IPOs
Icosavax
VLP platform
Icosavax raises $51M to take VLP RSV vaccine into humans
Fierce Biotech
Thu, 10/3/19 - 10:40 am
Icosavax
vaccines
RSV
VLP
viruslike particle
IVX-121